Cargando…

Daily Physical Activity in Asthma and the Effect of Mepolizumab Therapy

For the various asthma-specific beneficial effects of physical activity, daily physical activity (DPA) and the potential of asthma therapies on DPA require better characterization. Hence, we aimed to determine (a) the DPA of asthma patients, and (b) the effect of add-on mepolizumab on the DPA of sev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panagiotou, Marios, Koulouris, Nikolaos, Koutsoukou, Antonia, Rovina, Nikoletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605576/ https://www.ncbi.nlm.nih.gov/pubmed/36294831 http://dx.doi.org/10.3390/jpm12101692

Ejemplares similares

Physical Activity: A Missing Link in Asthma Care
por: Panagiotou, Marios, et al.
Publicado: (2020)

Immune Response to Mycobacterial Infection: Lessons from Flow Cytometry
por: Rovina, Nikoletta, et al.
Publicado: (2013)

Inflammation and Immune Response in COPD: Where Do We Stand?
por: Rovina, Nikoletta, et al.
Publicado: (2013)

Lung Microbiome in Asthma: Current Perspectives
por: Loverdos, Konstantinos, et al.
Publicado: (2019)

Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management
por: Kostakou, Eirini, et al.
Publicado: (2019)

Acid-Base Disturbances in Patients with Asthma: A Literature Review and Comments on Their Pathophysiology
por: Vasileiadis, Ioannis, et al.
Publicado: (2019)

Severe Pediatric Asthma Therapy: Mepolizumab
por: Ullmann, Nicola, et al.
Publicado: (2022)

Buffering Capacity in Sepsis: A Prospective Cohort Study in Critically Ill Patients
por: Vasileiadis, Ioannis, et al.
Publicado: (2019)

Implication of IL-18 in chronic inflammation of severe refractory asthma
por: Rovina, Nikoletta, et al.
Publicado: (2015)

COVID-19 ARDS: Points to Be Considered in Mechanical Ventilation and Weaning
por: Kondili, Eumorfia, et al.
Publicado: (2021)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

May mepolizumab used in asthma correct subfertility?
por: Ozden, Guzin, et al.
Publicado: (2021)

Fungal Infections in the ICU during the COVID-19 Era: Descriptive and Comparative Analysis of 178 Patients
por: Koukaki, Evangelia, et al.
Publicado: (2022)

Effectiveness of mepolizumab therapy on symptoms, asthma exacerbations, steroid dependence, and small airways in patients with severe eosinophilic asthma
por: YILMAZ, İnsu, et al.
Publicado: (2021)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
por: Yancey, Steven W., et al.
Publicado: (2019)

Characteristics of new adult users of mepolizumab with asthma in the USA
por: Wu, Ann Chen, et al.
Publicado: (2021)

Eosinophils depletion therapy for severe asthma management following favorable response to mepolizumab
por: Matsuno, Osamu, et al.
Publicado: (2019)

Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
por: Giovannini, Mattia, et al.
Publicado: (2019)

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study
por: Pavord, Ian, et al.
Publicado: (2023)

Prevalence and Characteristics of Self-Reported Adult Asthma in Cyprus: A Population-Based Observational Study
por: Benidis, Kleomenis D, et al.
Publicado: (2023)

Unraveling the Relationship of Asthma and COVID-19
por: Bakakos, Agamemnon, et al.
Publicado: (2021)

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
por: Numata, Takanori, et al.
Publicado: (2019)

Fungal Infections in Critically Ill COVID-19 Patients: Inevitabile Malum
por: Rovina, Nikoletta, et al.
Publicado: (2022)

Dexamethasone in the Treatment of COVID-19: Primus Inter Pares?
por: Romanou, Vasiliki, et al.
Publicado: (2021)

Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
por: Mukherjee, Manali, et al.
Publicado: (2017)

Role of mepolizumab in severe allergic asthma with vocal cord polyp
por: Karim, Azmat, et al.
Publicado: (2022)

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
por: Haldar, Pranabashis
Publicado: (2017)

Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
por: Moran, Angela M., et al.
Publicado: (2020)

Mepolizumab does not alter the blood basophil count in severe asthma
por: Wright, Adam Kelvin Alec, et al.
Publicado: (2019)

Effectiveness and safety of mepolizumab in severe refractory eosinophilic asthma: results in clinical practice
por: Montero-Pérez, Olalla, et al.
Publicado: (2019)

Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs
por: Llanos, Jean-Pierre, et al.
Publicado: (2020)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021)

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
por: Chapman, Kenneth R., et al.
Publicado: (2019)

Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities
por: Crimi, Claudia, et al.
Publicado: (2020)

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma
por: Silver, Jared, et al.
Publicado: (2020)

Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma
por: Howarth, Peter, et al.
Publicado: (2020)

Self-Administered Mepolizumab in the Management of Severe Asthma: Usability and Patient Acceptance
por: Miyokawa, Reika, et al.
Publicado: (2020)

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
por: Prazma, Charlene M, et al.
Publicado: (2021)

Outcomes over the first two years of treatment with mepolizumab in severe asthma
por: Elsey, Lynn, et al.
Publicado: (2021)

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
por: Gibson, Peter G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lqfb4cuesb40ef69hu20vfre2c